Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
about
Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.Effects of mineralocorticoid receptor antagonists on left ventricular mass in chronic kidney disease patients: a systematic review and meta-analysis.Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.
P2860
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@ast
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@en
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@nl
type
label
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@ast
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@en
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@nl
prefLabel
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@ast
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@en
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@nl
P356
P1433
P1476
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
@en
P2093
Andrew S. Bomback
P304
P356
10.1159/000441262
P407
P577
2016-01-01T00:00:00Z